HTG Molecular Diagnostics, Inc. Accounts Receivable, Credit Loss Expense (Reversal)

HTG Molecular Diagnostics, Inc. Accounts Receivable, Credit Loss Expense (Reversal)

HTG Molecular Diagnostics, Inc. reported Accounts Receivable, Credit Loss Expense (Reversal) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ProvisionForDoubtfulAccounts · last filed 2023-03-30

• HTG Molecular Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
• HTG Molecular Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2021 was $20.32K.
• HTG Molecular Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2015 was $44.85K, a 61.02% decline from fiscal 2014.
• HTG Molecular Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2014 was $115.07K.